Canada Pension Plan Investment Board’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,102,600
Closed -$10.2M 1401
2022
Q1
$10.2M Hold
1,102,600
0.01% 488
2021
Q4
$10.8M Buy
+1,102,600
New +$20.7M 0.01% 562

Other funds holding DCPH

Canada Pension Plan Investment Board's DCPH Position: Q2 2022 in Review

Canada Pension Plan Investment Board sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2022, closing a stake of 1,102,600 shares — an estimated $10.2M sold.

Canada Pension Plan Investment Board first reported a position in DCPH in Q4 2021 and held it in 2 quarters. The position peaked at $10.8M in Q4 2021. 128 funds tracked by Wall St. Rank hold DCPH as of Q2 2022.

  • Canada Pension Plan Investment Board reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 1,102,600 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $10.2M.
  • Canada Pension Plan Investment Board first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Canada Pension Plan Investment Board's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $10.8M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2022, filed 12 Aug 2022.